Advertising
Advertising
twitter
youtube
facebook
instagram
linkedin
Advertising

Expanding Diagnostic Services and Strategic Investments: Voxel's Growth Plans for the Year Ahead

Expanding Diagnostic Services and Strategic Investments: Voxel's Growth Plans for the Year Ahead
Aa
Share
facebook
twitter
linkedin

This year the Group expects a higher volume of diagnostic services, exceeding 385,000 procedures compared to 373,000 provided at Voxel, RP, Scanix last year (2x2H22).

More efficient usage of active labs and faster processing of scans should support the profitability. The Group carries out investments in 2 new MRI laboratories Będzin and Sędziszów and replaces a CT scanner in Bydgoszcz. A launch of a new CT laboratory is planned in Kraków, MRI and CT scanners will be replaced in Warsaw (MRI, CT) and Bytom (CT).

Besides, the Group looks at takeover targets and considers options to lower losses generated by the hospital business or soften the impact it exerts on the Group’s financials. According to our estimates, the hospital business may burden the Company’s consolidated EBIT by c. PLN 6 million.

The current restructuring includes (i) reducing the number of hospital beds in the internal diseases ward with their increase elsewhere, (ii) a hospital stay optimization with more efficient use of hospitals beds, (iii) providing services within the framework of the colorectal cancer screening program (from December 1, 2022), (iv) increasing the medical staff in endoscopic units, (v) salary costs restructuring, and (vi) starting the cooperation in the clinical tests area.

 

expanding diagnostic services and strategic investments voxel s growth plans for the year ahead grafika numer 1expanding diagnostic services and strategic investments voxel s growth plans for the year ahead grafika numer 1


GPW’s Analytical Coverage Support Programme 3.0

GPW’s Analytical Coverage Support Programme 3.0

The Warsaw Stock Exchange's (GPW's) Analytical Coverage Support Programme 3.0 supports investment firms in drafting analytical reports which are financed by GPW. The objective of the Programme is to improve the availability of research covering less liquid companies, facilitating investors' informed investment decisions based on a reliable independent source of issuer information. Eligible to participate in the Programme are companies listed on the GPW Main Market (other than WIG20 participants) and on NewConnect. The Programme covers up to 50 issuers.

Twitter | LinkedIn 


Topics

Advertising
Advertising